Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cellsChihiro Nakahara, Katsuya Nakamura, Naoki Yamanaka, et al.
Anticancer Research|December 12, 2003
Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusionTakashi Morisaki, Kotaro Matsumoto, Hideo Kuroki, et al.
Anticancer Research|May 6, 2009
The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancerChizu Kameda, Haruo Tanaka, Akio Yamasaki, et al.
Anticancer Research|May 30, 2012
Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancerMakoto Kubo, Hideya Onishi, Syoji Kuroki, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2004
Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin productionMakoto Kubo, Takashi Morisaki, Kotaro Matsumoto, et al.
Cancer Science|April 16, 2008
Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activationShuntaro Nagai, Masafumi Nakamura, Kosuke Yanai, et al.
Anticancer Research|May 30, 2008
Novel link between estrogen receptor alpha and hedgehog pathway in breast cancerKenichiro Koga, Masafumi Nakamura, Hiroshi Nakashima, et al.
Anticancer Research|December 12, 2003
Combination of adoptive immunotherapy with Herceptin for patients with HER2-expressing breast cancerMakoto Kubo, Takashi Morisaki, Hideo Kuroki, et al.
Anticancer Research|May 25, 2004
Nuclear factor-kappaB p65 is a prognostic indicator in gastric carcinomaNaoki Yamanaka, Nobuhiko Sasaki, Akira Tasaki, et al.
Cancer Letters|January 23, 2016
CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cellsKumi Suyama, Hideya Onishi, Akira Imaizumi, et al.
Pageof 10